no evidence of diseae activity (NEDA)
Showing 1 - 25 of >10,000
Neurofilaments for NEDA Assessing in MS
Terminated
- Multiple Sclerosis
-
London, England, United KingdomQueen Mary University of London
Feb 9, 2022
Relapsing-Remitting Multiple Sclerosis Trial in Hamburg, Mannheim (Autologous Hematopoietic Stem Cell Transplantation,
Terminated
- Relapsing-Remitting Multiple Sclerosis
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Hamburg, Germany
- +1 more
Mar 1, 2022
Silent Progression Activity Monitoring - SPAM Study
Not yet recruiting
- Multiple Sclerosis
- NO INTERVENTION
-
Nice, FranceCHU de Nice
Dec 5, 2022
Cancer Survivor, Central Obesity, No Evidence of Disease Trial in Los Angeles (other, behavioral, device)
Withdrawn
- Cancer Survivor
- +2 more
- Best Practice
- +5 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Dec 15, 2020
Multiple Sclerosis, Relapsing-Remitting Trial in Amsterdam (Ocrelizumab)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location VU
Apr 21, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Switzerland (serum Neurofilament Filament Light chain (sNfL) monitoring)
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- serum Neurofilament Filament Light chain (sNfL) monitoring
-
Basel, Basel Stadt, Switzerland
- +7 more
Oct 17, 2023
Behavior, Child, Physical Inactivity Trial in Istanbul (Intervention group)
Recruiting
- Behavior, Child
- Physical Inactivity
- Intervention group
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
Dec 28, 2022
Chronic Disease, Exercise, Physical Activity Trial in Greenville (Invitation to adopt)
Recruiting
- Chronic Disease
- +2 more
- Invitation to adopt
-
Greenville, South CarolinaPrisma Health
Oct 2, 2023
Kesimpta® in Swiss Multiple Sclerosis Patients -Observational
Recruiting
- Multiple Sclerosis
- Ofatumumab
-
Baden, Aargau, Switzerland
- +17 more
Jan 20, 2023
Ofatumumab in Portuguese Multiple Sclerosis Patients
Not yet recruiting
- Relapsing Multiple Sclerosis
- Ofatumumab
- (no location specified)
Mar 30, 2023
Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae
Recruiting
- Batten Disease
- CLN6
- Natural history
-
Columbus, OhioNationwide Children's Hospital
Oct 20, 2022
Hernia Incisional, Exercise Trial in Germany, Switzerland (Physiotherapy)
Recruiting
- Hernia Incisional
- Exercise
- Physiotherapy
-
Koblenz, Germany
- +4 more
Nov 7, 2022
Interstitial Lung Disease Trial in Istanbul (Exercise)
Recruiting
- Interstitial Lung Disease
- Exercise
-
Istanbul, Turkeyİstanbul Faculty of Medicine
Oct 13, 2023
Physical Activity, Exercise, Acute Leukemia Trial in Chapel Hill, Durham (Build Stamina Program)
Completed
- Physical Activity
- +4 more
- Build Stamina Program
-
Chapel Hill, North Carolina
- +1 more
Sep 22, 2022
Childhood Obesity, Physical Activity Trial in Taif (I'm an Active Hero (IAAH) Intervention Program)
Not yet recruiting
- Childhood Obesity
- Physical Activity
- I'm an Active Hero (IAAH) Intervention Program
-
Taif, Maccha, Saudi ArabiaGeneral Administration of Education in Taif-KSA
Mar 1, 2023
Cardiovascular Diseases, Obesity Trial in Saint Louis (PREVENT tool, Wait-list Control)
Completed
- Cardiovascular Diseases
- Obesity
- PREVENT tool
- Wait-list Control
-
Saint Louis, MissouriWashington University in St. Louis
Nov 7, 2023
Urinary Incontinence Trial in Ottawa (Pessary Intervention, Tampon Intervention)
Not yet recruiting
- Urinary Incontinence
- Pessary Intervention
- Tampon Intervention
-
Ottawa, Ontario, CanadaMcLean Function Measurement Lab
Mar 6, 2023
Multiple Sclerosis, Relapsing-Remitting, Caloric Restriction Trial in Pozzilli (Caloric restriction, Caloric restriction without
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Caloric Restriction
- Caloric restriction
- Caloric restriction without cow's milk and gluten
-
Pozzilli, IS, ItalyNeuromed - Istituto Neurologico Mediterraneo Pozzilli
Jul 26, 2022
Multiple Sclerosis Trial in France (DMT withdrawal, DMT continuation)
Recruiting
- Multiple Sclerosis
- DMT withdrawal
- DMT continuation
-
Angers, France
- +22 more
Mar 25, 2022
Sarcoma Trial in Guangzhou (chidamide and toripalimab)
Recruiting
- Sarcoma
- chidamide and toripalimab
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Univerisity
Sep 4, 2022
Stress Urinary Incontinence, Patient Satisfaction, Surgery Trial in Great Neck (No activity restrictions, Activity restrictions)
Completed
- Stress Urinary Incontinence
- +2 more
- No activity restrictions
- Activity restrictions
-
Great Neck, New YorkNorth Shore University Hospital
Feb 2, 2023
Aging Trial (Adjusted Cognitive-biased modification task, Cognitive-biased modification task)
Not yet recruiting
- Aging
- Adjusted Cognitive-biased modification task
- Cognitive-biased modification task
- (no location specified)
Jan 26, 2023
Aging Trial in Chicago (BAILAMOS™ @home/en casa, ¡En Forma y Fuerte! @home/en casa)
Not yet recruiting
- Aging
- BAILAMOS™ @home/en casa
- ¡En Forma y Fuerte! @home/en casa
-
Chicago, IllinoisUniversity of Illinois at Chicago
Oct 18, 2022
Obesity Trial in Lexington, Chapel Hill (Enhanced Go NAPSACC, Basic Go NAPSACC)
Active, not recruiting
- Obesity
- Enhanced Go NAPSACC
- Basic Go NAPSACC
-
Lexington, Kentucky
- +1 more
Oct 25, 2022